Market Cap 702.70M
Revenue (ttm) 219.79M
Net Income (ttm) -57.47M
EPS (ttm) N/A
PE Ratio 125.10
Forward PE N/A
Profit Margin -26.15%
Debt to Equity Ratio 0.02
Volume 508,800
Avg Vol 401,650
Day's Range N/A - N/A
Shares Out 28.01M
Stochastic %K 11%
Beta 0.92
Analysts Strong Sell
Price Target $41.00

Latest News on CSTL

Castle Biosciences Reports Third Quarter 2024 Results

Nov 4, 2024, 4:05 PM EST - 2 months ago

Castle Biosciences Reports Third Quarter 2024 Results


Castle Biosciences: Inflection Into Profitability

Aug 16, 2024, 6:41 AM EDT - 5 months ago

Castle Biosciences: Inflection Into Profitability


Castle Biosciences, Inc. (CSTL) Q2 2024 Earnings Call Transcript

Aug 5, 2024, 10:35 PM EDT - 5 months ago

Castle Biosciences, Inc. (CSTL) Q2 2024 Earnings Call Transcript


Castle Biosciences Reports Second Quarter 2024 Results

Aug 5, 2024, 4:05 PM EDT - 5 months ago

Castle Biosciences Reports Second Quarter 2024 Results


Castle Biosciences Honored with Top Workplaces Awards

Jul 11, 2024, 7:00 AM EDT - 6 months ago

Castle Biosciences Honored with Top Workplaces Awards


Top 5 Health Care Stocks That May Explode In July

Jul 8, 2024, 8:40 AM EDT - 6 months ago

Top 5 Health Care Stocks That May Explode In July

NRC OMI PCRX SAVA


Castle Biosciences Reports First Quarter 2024 Results

May 2, 2024, 4:05 PM EDT - 9 months ago

Castle Biosciences Reports First Quarter 2024 Results